Vendor also unveils MacroVision softwareThe trickle of nuclear medicine vendors with digital gamma cameradetectors became a flood at this month's Radiological Societyof North America meeting. Several vendors unveiled developmentsin digital
The trickle of nuclear medicine vendors with digital gamma cameradetectors became a flood at this month's Radiological Societyof North America meeting. Several vendors unveiled developmentsin digital detector technology, including Siemens, Sopha Medicaland market leader ADAC Medical Systems.
ADAC, of Milpitas, CA, began delivering its Epic digital detectorsimmediately after the RSNA meeting. The detectors will be shippedon all ADAC's rectangular-head gamma cameras, including the single-headand dual-head Genesys models and adjustable dual-head Vertex,according to Ian Farmer, director of nuclear medicine marketing.ADAC will no longer offer analog detectors on rectangular-headcameras, Farmer said. ADAC cameras in the field are not retrofittableto digital.
Epic uses a non-Anger method of digitization, in which analogsignals are converted to digital immediately after each photomultipliertube, Farmer said. The vendor compares its approach to non-Angerdigital gamma cameras manufactured by Summit Nuclear and ParkMedical.
Going digital has enabled ADAC to double the count rate ofits detectors, which are now capable of 200,000 counts per secondat the 20% energy window. Epic detectors also have improved resolution,linearity, uniformity and energy resolution.
Besides improving camera performance, digital detectors willallow ADAC customers to make upgrades in the future through softwareenhancements rather than hardware changes. Epic's digital technologyalso enables the development of remote servicing and diagnosticscapabilities. ADAC has boosted the list price of Epic gamma camerasslightly to account for the new technology.
In addition to digital, ADAC unveiled its new MacroVision programmingenvironment for developing nuclear medicine applications and protocols.Due to its object-oriented design, MacroVision expands the numberof gamma camera users who can develop new applications withoutgoing through the time-intensive process of writing computer code,according to Farmer.
Finally, ADAC displayed its work in non-uniform attenuationcorrection with Vantage, an investigational device that uses twoline sources of radiation mounted on Vertex with the detectorsin the 90_ position (SCAN 11/23/94). Because of the 90_ configurationand ADAC's narrow-beam line-source collimation, Vertex with Vantagecan complete cardiac protocols in 10 minutes versus 18 to 20 minuteson a triple-head camera using attenuation correction, accordingto Farmer.
ADAC hopes its technological advancements will help it seizeadditional market share, which stood at 34.5% at the end of September,according to the most recent National Electrical ManufacturersAssociation survey. The dollar sales of ADAC's Vertex camera alonenow exceed sales of the entire nuclear medicine lines of eitherSiemens or GE, according to Farmer.
"We can offer attenuation correction and digital detectorsin the future, and no other vendor can offer this," Farmersaid. "It will cause ADAC to grow its market share so morecustomers will want to buy ADAC products versus those of othervendors."
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.